World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-ICR-15005879
Date of registration: 2015-01-24
Prospective Registration: Yes
Primary sponsor: Department of Neonatology, Tongji Hospital, Huazhong University of Science and Technology
Public title: Infant Flow bi-level nasal positive airway pressure (BiPAP) vs. Infant Flow nasal continuous positive airway pressure (CPAP) in preterm infants less than 1500g with respiratory distress syndrome following INSURE treatment: a multicenter randomised controlled trial(RCT)
Scientific title: Infant Flow bi-level nasal positive airway pressure (BiPAP) vs. Infant Flow nasal continuous positive airway pressure (CPAP) in preterm infants less than 1500g with respiratory distress syndrome following INSURE treatment: a multicenter randomised controlled trial(RCT)
Date of first enrolment: 2015-02-01
Target sample size: 1:130;2:130;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10326
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  New Treatment Measure Clinical Study
Countries of recruitment
China
Contacts
Name: Rong Zhihui   
Address:  Department of Neonatology, Tongji Hospital, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, China 430030
Telephone: +86 13871530925
Email: rongzhihui53@163.com
Affiliation:  Department of Neonatology, Tongji Hospital, Huazhong University of Science and Technology
Name: Rong Zhihui   
Address:  Department of Neonatology, Tongji Hospital, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, China 430030
Telephone: +86 13871530925
Email: rongzhihui53@163.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Infants of birth weight less than 1500g, inborn, affected by RDS following INSURE treatment, were considered eligible in Tongji Hospital and Xiangyang Central Hospital. RDS was diagnosed within four hour of life on radiological and clinical criteria. The RDS diagnosis was based on the classic symptoms such as the need for oxygen supplement, tachypnea, retraction and grunting. RDS was confirmed by typical radiological pattern with decreased lung expansion with reticulogranular pattern and air bronchograms.
Exclusion criteria: Infants with lethal congenital anomalies, congenital abnormalities of the upper airway tract were excluded.

Age minimum: 0
Age maximum: 0
Gender: Both
Health Condition(s) or Problem(s) studied
bronchopulmonary dysplasia
Intervention(s)
1:SiPAP;2:CPAP;
Primary Outcome(s)
BPD;sustained extubation for 7 days;physical growth, lung function and the neurological examination results at 2 years of age;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Canada-China Clinical Research Program MOH Key Laboratory of Neonatal Diseases, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history